Table 5.

Comparison of clinical and trichoscopic features between Group 3 (duration of COVID-19 infection ≤ 2 weeks) and Group 4 (duration of COVID-19 infection > 2 weeks).

Variable	Group 3 ≤ 2 weeks (N = 68)	Group 4 >2 weeks (N = 52)	P-value
Age (years)	35.9± 11.82	44.48 ± 11.49	0.001
Mean time of onset of hair loss post COVID-19 infection (days)	50.3 ± 34.2	47.9 ± 25.6	0.901
Place of management
Home	65 (95.6%)	39 (75.0%)	0.001
Hospitalized	3 (4.4%)	13 (25.0%)
Mean VAS score	4.60±2.80	6.10±2.60	0.004
Pattern of current hair loss
Diffuse	44 (64.7%)	37 (71.2%)	0.336
MPHL	13 (19.1%)	11 (21.2%)
FPHL	6 (8.8%)	3 (5.8%)
Diffuse and FPHL	4 (5.9%)	0 (0%)
Diffuse and MPHL	1 (1.5%)	0 (0%)
Diffuse and AA	0 (0%)	1 (1.9%)
Degree of hair loss
Mild	3 (4.4%)	5 (9.6%)	0.011
Moderate	33 (48.5%)	12 (23%)
Severe	32 (47.1%)	35 (67.3%)
Trichoscopic features
Single hair follicle	56 (82.4%)	42 (80.8%)	0.824
Vellus hair >10%	38 (55.9%)	34 (65.4%)	0.292
Empty hair follicles	34 (50.0%)	27 (51.9%)	0.835
Anisotrichosis	28 (41.2%)	24 (46.2%)	0.586
Increased Interfollicular distance	27 (39.7%)	23 (44.2%)	0.618
Perifollicular scaling	15 (22.1%)	18 (34.6%)	0.127
Perifollicular pigment	10 (14.7%)	7 (13.5%)	0.846
Yellow dots	8 (11.8%)	7 (13.5%)	0.781

AA = Alopecia areata; FPHL = Female pattern hair loss; MPHL = Male pattern hair loss; VAS: =Visual analogue scale.